Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...

Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive, according to a 'game-changer' study. Patients with advanced ...

They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...